GUK-based Oxford BioDynamics has automated its proprietary biomarker discovery platform, EpiSwitch™, on a Freedom EVO® 150, helping to establish a NGS, CGH-array and PCR-based pipeline for the discovery of novel biomarkers, as well as a PCR protocol for biomarker-based diagnostic testing.
